Mkts

Ionis Pharmaceuticals, Inc.

NASDAQ: IONS
$43.42+0.49 (+1.14%)
As of Oct 26, 4:00 PM ET

Key statistics

Day range
42.7643.92
52-week range
42.0886.74
Today
Open43.00
Previous close43.42
Volume—
Valuation
Market cap7.12B
P/E ratio—
EPS (TTM)-3.47
Income & risk
Dividend / yield—
Beta0.39
Avg volume3.44M
Discussion

IONS News

Stories mentioning IONS from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue246,091203,330156,719452,049131,612226,577133,814225,250
Cost of Goods Sold2,9837,9572,3384,1511,4633,8291,0714,164
Gross Profit243,108195,374154,381447,898130,149222,748132,743221,086
Operating Expenses
Research & Development
Sales General & Admin150,359130,18696,80990,62276,25088,07961,63865,113
Total Operating Expenses
Operating Income (Loss)(117,424)(214,459)(160,182)139,816(146,860)(110,821)(148,656)(66,091)
Interest Income
Interest Expense5,1604,8284,2124,1144,1084,1924,1614,490
Other Expense(456.00)(16,288)363.00102.00465.00302.00142.00610.00
Pretax Income(92,310)(227,917)(128,393)123,531(146,822)(107,038)(144,101)(66,201)
Tax Provision218.001,477213.00(20.00)116.00(2,689)(3,621)64.00
Net Income (Loss)(92,528)(229,394)(128,606)123,551(146,938)(104,349)(140,480)(66,265)
Earnings Per Share (Basic)(0.56)(1.41)(0.80)0.78(0.93)(0.66)(0.95)(0.45)
Earnings Per Share (Diluted)(0.56)(1.41)(0.80)0.70(0.93)(0.66)(0.95)(0.45)
Weighted Average Shares Outstanding (Basic)164,874160,010159,765159,137158,735149,514148,593145,958
Weighted Average Shares Outstanding (Diluted)164,874160,010159,765182,331158,735149,514148,593145,958

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About IONS

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) is a stock listed on the Nasdaq Stock Market under the ticker symbol IONS. It last traded at $43.42 (Oct 26, 2026, 4:00 PM ET), up 1.1% on the day. That gives Ionis Pharmaceuticals a market capitalisation of $7.1B.

Over the past 52 weeks IONS has traded between $42.08 and $86.74.

Revenue for the quarter ended Mar 31, 2026 was $246.1M; a net loss of $92.5M. Revenue was up 87.0% from $131.6M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$246.1M-$92.5M-37.6%
Dec 31, 2025$203.3M-$229.4M-112.8%
Sep 30, 2025$156.7M-$128.6M-82.1%
Jun 30, 2025$452.0M$123.6M27.3%

From Ionis Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…